Brucellosis

Infectious Diseases in Clinical Practice

Volumn 12, Issue 1, 2004, Pages 7-14

  Lim, Matthew L ^a   Rickman, Leland S ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE DERIVATIVE;

BACTERIAL TRANSMISSION; BRUCELLA ABORTUS; BRUCELLA CANIS; BRUCELLA MELITENSIS; BRUCELLA SUIS; BRUCELLOSIS; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DRUG EFFICACY; HUMAN; INFECTION RISK; MENINGITIS; NONHUMAN; OSTEOMYELITIS; OTOTOXICITY; PATHOGENESIS; RECURRENT DISEASE; REVIEW; SPONDYLITIS;

EID: 1642554395     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000104894.16995.c4     Document Type: Review

References (75)

1. Wright SG. Brucellosis. In Hunter's Tropical Medicine and Emerging Infectious Diseases, 8th ed. Philadelphia: WB Saunders; 2000;P416.
2. Capasso L. Bacteria in two-millenia-old cheese, and related epizoonoses in Roman populations. J Infect. 2002;45(2):122-127.
3. Spink WW. The significance of bacterial hypersensitivity in human brucellosis: studies on infection due to strain 19 Brucella abortus. Ann Intern Med. 1957;47:861-874.
4. Braude AI. Studies in the pathology and pathogenesis of experimental brucellosis: I and II. J Infect Dis. 1951;89:76-87.
5. Braude AI, Carey FJ, Sutherland D, et al. Overwhelming bacteremic shock produced by gram-negative bacilli: a report of 4 cases with one recovery. Univ Mich Med Bull. 1953;19:23.
6. Young EJ. Brucclla Species. In: Principles and Practice of Infectious Diseases, 5th edition, ed by Mandell GL, Bennett JE, Dolin R. Philadelphia: Churchill Livingston. 2388.
7. Cattle Brucellosis Eradication in Texas: close, but not yet. Press Release from the Texas Animal Health Commission, Oct 1 2003. Available at www.tahc.state.tx.us/news/pr/2003/2003Oct_Brucellosis_Erad.pdf.
8. Doyle TJ, Bryan RT. Infectious disease morbidity in the US region bordering Mexico 1990-1998. Clin Infect Dis. 2000;182:1503-1510.
9. Landau Z, Green L. Chronic brucellosis in workers in a meat-packing plant. Scand J Infect Dis. 1999;31:511-512.
10. Alibek K. Biohazard. New York: Dell Publishing; 93.
11. Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis. 1994;170:1216-1223.
12. Arnow PM, Smaron M, Ormiste V. Brucellosis in a group of travelers to Spain. JAMA. 1984;251(4):505-507.
13. Ruben B, Band JD, Wong P, et al. Person to person transmission of Brucella melitensis. Lancet. 1991;337:14-15.
14. Staszkiewicz J, Lewis CM, Colville J, et al. Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol. 1991;29(2):287-290.
15. Fiori PL, Mastrandrea S, Rappelli P, et al. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol. 2000;38(5): 2005-2006.
16. Yagupsky P, Peled N, Riesenberg K, et al. Exposure of hospital personnel to Brucella melitensis and occurrence of laboratory-acquired disease in an endemic area. Scand J Infect Dis. 2000;32:31-35.
17. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995; 21:283-290.
18. Malik GM. A clinical study of brucellosis in adults in the Asir region of southern Saudi Arabia. Am J Trop Med Hyg. 1997;56(4):375-377.
19. Young EJ. Brucella melitensis hepatitis: the absence of granulomas. Ann Intern Med. 1979;91(3):414-415.
20. Alcala L, Munoz P, Creizems-Rodriguez M. Brucella spp. peritonitis [letter]. Am J Med. 1999;107:300.
21. Al Awadhi NZ, Ashkenani F, Khalaf ES. Acute pancreatitis associated with brucellosis. Am J Gastroenterol. 1989;84(12):1570-1574.
22. Al Faraj S. Acute abdomen as atypical presentation of brucellosis: report of two cases and review of literature. J R Soc Med. 1995;88:91-92.
23. Vargas V, Comas P, Llatzer R, et al. Brucellar hepatic abscess [letter]. J Clin Gastroenterol. 1991;13:477-478.
24. Ariza J, Pigrau C, Canas C, et al. Current understanding and management of chronic hepatosplenic suppurative Brucellosis. Clin Infect Dis. 2001;32:1024-1033.
25. Gonzalez-Gay MA, Garcia-Porrua C, Ibanez D, et al. Osteoarticular complications of brucellosis in il an Atlantic area of Spain. J Rheumatol. 1999;26(1):141-145.
26. Khateeb MI, Araj GF, Majeed SA, et al. Brucella arthritis: a study of 96 cases in Kuwait. Ann Rheum Dis. 1990;49:994-998.
27. Zaks N, Sukenik S, Alkan M, et al. Musculoskeletal manifestations of brucellosis: a study of 90 cases in Israel. Semin Arthritis Rheum. 1995; 25(2):97-102.
28. Navarro V, Solera J, Martinez-Alfaro E, et al. Brucellar osteomyelitis involving prosthetic extra-articular hardware. J Infect. 1997;35(2): 192-194.
29. Weil Y, Mattan Y, Liebergall M, et al. Brucella prosthetic joint infection: a report of 3 cases and a review of the literature. Clin Infect Dis. 2003;36(7):e81-e86.
30. Tekkok IH, Berker M, Ozcan OE, et al. Brucellosis of the spine. Neurosurgery. 1993;33(5):838-844.
31. Solera J, Lozano E, Martinez-Alfaro E, et al. Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis. 1999;29:1440-1449.
32. Jacobs F, Abramowicz D, Vereerstraeten P, et al. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis. 1990;12(5):740-744.
33. Keles C, Bozbuga N, Sismanoglu M, et al. Surgical treatment of Brucella endocarditis. Ann Thorac Surg. 2001;71(4):1160-1163.
34. Cohen N, Golik A, Alon I, et al. Conservative treatment for Brucella endocarditis. Clin Cardiol. 1997;20:291-294.
35. Mili N, Auckenthaler R, Nicod LP. Chronic Brucella empyema [letter]. Chest. 1993;103(2):620-621.
36. Ibrahim AI, Awad R, Shetty SD, et al. Genito-urinary complications of brucellosis. Br J Urol. 1988;61(4):294-298.
37. Al Deeb SM, Yaqub BA, Sharif HS, et al. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology 1989;39:498-501.
38. Bucher A, Gaustad P, Pape E. Chronic neurobrucellosis due to Brucella melitensis. Scand J Infect Dis. 1990;22:223-226.
39. Fincham RW, Sahs AL, Joynt RL. Protean manifestations of nervous system brucellosis. JAMA. 1963;184(4):269-275.
40. Bashir R, al Kawi Z, Harder EJ, et al. Nervous system brucellosis: diagnosis and treatment. Neurology. 1985;35:1576-1581.
41. Al Deeb SM, Yaqub BA, Sharif HS, et al. Neurobrucellosis: clinical characteristics, diagnosis, and outcome. Neurology. 1989;39:498-501.
42. Abd Elrazek M. Brucella optic neuritis. Arch Intern Med. 1991;151: 776-778.
43. Shoshan Y, Maayan S, Gomori MJ, et al. Chronic subdural empyema: a new presentation of neurobrucellosis. Clin Infect Dis. 1996;23:400-401.
44. Bouza E, Garcia de la Torre M, Parras F, et al. Brucellar meningitis. Rev Infect Dis. 1987;9(4):810-822.
45. Lubani MM, Dudin KI, Araj GF, et al. Neurobrucellosis in children. Pediatr Infect Dis. 1989;8(2):79-82.
46. Gottesman G, Vanunu D, Maayan MC, et al. Childhood brucellosis in Israel. Pediatr Infect Dis J. 1996;15(7):610-615.
47. Al-Eissa Y, Kambal AM, Al-Nasser MN, et al. Childhood brucellosis: a study of 102 cases. Pediatr Infect Dis J. 1990;9(2):74-79.
48. Khan MY, Mah MW, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001;32:1172-1177.
49. Moreno S, Ariza J, Espinosa FJ, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1998;17:319-326.
50. Paul J, Gilks C, Batchelor B, et al. Serological responses to brucellosis in HIV-seropositive patients. Trans R Soc Trop Med Hyg. 1995;89(2): 228-230.
51. Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol. 1999;37(11):3437-3442.
52. Gotuzzo E, Carrillo C, Guerra J, et al. An evaluation of diagnostic methods for brucellosis: the value of bone marrow culture. J Infect Dis. 1986;153(1):122-125.
53. Young E. Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991;13:359-372.
54. Queipo-Ortuno MI, Morata P, Ocon P, et al. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol. 1997; 35(11):2927-2930.
55. Morata P, Queipo-Ortuno MI, Reguera JM, et al. Posttreatment follow-up of brucellosis by PCR assay. J Clin Microbiol. 1999;37(12): 4163-4166.
56. Solera J, Espinosa A, Martinez-Alfaro E, et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother. 1997;41(1):80-84.
57. Ariza J, Gudiol F, Pallares R, et al. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother. 1985;28:548-551.
58. Acocella G, Bertrand A, Beytout J, et al. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother. 1989;23(3):433-439.
59. Solera J, Rodriguez-Zapata M, Geijo P, et al. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother. 1995;39(9): 2061-2067.
60. Colmenero JD, Hernandez S, Reguera JM, et al. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy. 1989;35:146-152.
61. Ariza J, Gudiol F, Pallares R, et al. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin: a randomized, double-blind study. Ann Intern Med. 1992;117:25-30.
62. Montejo JM, Alberola I, Gonzalez-Zarate P, et al. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis. 1993;16:671-676.
63. Ariza J, Gudiol F, Pallares R, et al. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in human brucellosis [letter]. J Infect Dis. 1985;152:1358.
64. Solera J, Beato JL, Martinez-Alfaro E, et al. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. Clin Infect Dis. 2001;32;506-509.
65. Al Sibai MB, Halim MA, el-Shaker MM, et al. Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrob Agents Chemother. 1992;36(1):150-152.
66. Doganay M, Aygen B. Use of ciprofloxacin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1992;11:74-75.
67. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol Infect Dis. 1999;18:535-538.
68. Akova M, Uzun O, Akalin HE, et al. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrob Agents Chemother. 1993;37(9):1831-1834.
69. Ariza J, Corredoira J, Pallares R, et al. Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis. 1995;20: 1241-1249.
70. Lubani MM, Dudin KI, Sharda DC, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8(2): 75-78.
71. De Rautlin de la Roy YM, Grignon B, Grollier B, et al. Rifampicin resistance in a strain of Brucella melitensis after treatment with doxycycline and rifampicin. J Antimicrob Chemother. 1986;18(5):648-649.
72. Al-Sibai MB, Qadri SM. Development of ciprofloxacin resistance in Brucella melitensis. J Antimicrob Chemother. 1990;25(2):302-303.
73. Ariza J, Bosch J, Gudiol F, et al. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother. 1986;30(6):958-960.
74. Abramson O, Rosenvasser Z, Block C, et al. Detection and treatment of brucellosis by screening a population at risk. Pediatr Infect Dis J. 1991;10(6):434-438.
75. Human exposure to Brucella abortus strain RB51-Kansas 1997. In Morbidity and Mortality Weekly Report. 1998;47(09):172-175.